{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-176540","form_type":"8-K","ticker":"NERV","cik":"0001598646","company_name":"Minerva Neurosciences, Inc.","filed_at":"2022-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.383201+00:00","generated_at":"2026-06-25T00:52:51.528318+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Minerva Neurosciences files for 1-for-8 reverse stock split effective June 17, 2022","bullets":["Stockholders approved reverse split at June 10, 2022 annual meeting; board set ratio at 1-for-8.","Split effective 5:00 PM ET June 17; common stock begins trading split-adjusted on Nasdaq June 21.","No fractional shares issued; cash paid in lieu. New CUSIP number is 603380 205.","Proportionate adjustments made to all outstanding equity awards and shares reserved under equity plans."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-176540","json":"https://secwatch.observer/filing/0001193125-22-176540.json","markdown":"https://secwatch.observer/filing/0001193125-22-176540.md","text":"https://secwatch.observer/filing/0001193125-22-176540.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1598646/000119312522176540/0001193125-22-176540-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1598646/000119312522176540/d314076d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T00:52:51.528318+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}